Evidence map›Paper›PMID 41226251›Full record

ArticleMolecules (Basel, Switzerland)2025

Kinetics and Isotherm Study of Ceftriaxone Removal Using Functionalized Biochar Combined with Photocatalysis.

Luísa Cruz-Lopes, Rodrigo Araújo, Ana Rita Lopes, Samuel Moles, Francisca Romero-Sarria, Bruno Esteves

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luísa Cruz-LopesCERNAS (Centre for Natural Resources, Environment and Society)-IPV Research Centre, Polytechnic University of Viseu, Av. Cor. José Maria Vale de Andrade, 3504-510 Viseu, Portugal.ORCID 0000-0001-6502-7202
Rodrigo AraújoDepartment of Environmental Engineering, Polytechnic University of Viseu, Av. Cor. José Maria Vale de Andrade, 3504-510 Viseu, Portugal.
Ana Rita LopesFaculty of Dental Medicine, Universidade Católica Portuguesa, 3504-505 Viseu, Portugal.ORCID 0000-0002-4415-7558
Samuel MolesInstituto de Investigación en Ciencias Ambientales de Aragón (IUCA), Universidad de Zaragoza, c. de Pedro Cerbuna, 12, 50009 Zaragoza, Spain.ORCID 0000-0002-1401-7511
Francisca Romero-SarriaDepartment of Inorganic Chemistry and Institute of Materials Science, Joint Center University of Seville-CSIC, Av. Américo Vespucio, 41092 Seville, Spain.
Bruno EstevesCERNAS (Centre for Natural Resources, Environment and Society)-IPV Research Centre, Polytechnic University of Viseu, Av. Cor. José Maria Vale de Andrade, 3504-510 Viseu, Portugal.ORCID 0000-0001-6660-3128

Funding

Fundação para a Ciência e Tecnologia UIDB/00681
6 · The paper itself

Abstract

The increasing presence of antibiotics such as cephalosporins in wastewater represents a significant environmental risk. These compounds are excreted in large quantities, and conventional wastewater treatment plants are often ineffective at their removal. Consequently, the development of more sustainable and efficient treatment technologies is essential. In this study, the removal of cephalosporins from aqueous solutions was evaluated through adsorption using pine bark biochar, photocatalysis with TiO

Indexed as

CeftriaxoneCharcoalWater Pollutants, ChemicalAdsorptionAnti-Bacterial AgentsCatalysisKineticsPhotolysisTitaniumWastewaterWater PurificationAnti-Bacterial AgentsbiocharCeftriaxoneCharcoalTitaniumtitanium dioxideWastewaterWater Pollutants, Chemicalantibioticbiocharceftriaxone sodiumcephalosporinsphotocatalysiswastewater treatment

Identifiers

PMID41226251
PMCPMC12608820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.